Searched for
TARO PHARMACEUTICALS
Sun Pharma-Organon deal: How a $12-billion merger will reshape India's pharma landscapeSun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The ...- Sun's strong gravity helps India Inc's pullSun Pharma has expanded its horizons by acquiring Organon, a notable New Jersey pharmaceutical firm. This strategic acquisition fortifies S...
- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Sun Pharma arm recalls over 17,000 units of antifungal shampoo in US: USFDATaro Pharmaceutical Industries, a Sun Pharma unit, is recalling 17,664 units of Ciclopirox Shampoo in the US. The antifungal medication is ...
- Sun Pharma's US subsidiary acquires Galderma's companies in US, Japan & CanadaTaro has paid around $99.3 million after taking into account working capital adjustments.
- Sun Pharma's arm Taro resolves all cases with United States Department of JusticeUnder a deferred prosecution agreement reached with the DOJ, it said, adding that the dept will file an information for conduct that took p...
- Taro appoints Sun Pharma CFO Uday Baldota its CEOBaldota, who has also been nominated to Taro's board of directors, is expected to begin his role as CEO on or about April 1, 2017, and will...
- Taro Pharmaceutical Industries under anti-trust scanner for price hike“We have no additional comments to offer on this matter,” said a Sun Pharma executive to an email query. Sun Pharma's shares on Monday clos...
- Sun Pharma's arm Taro plans shares repurchase worth $250 millionThe board of directors of Taro Pharmaceutical Industries approved a $250 million share repurchase authorisation of its ordinary shares.
- Taro postpones shareholders meeting on merger with Sun PharmaIsraeli firm Taro Pharmaceutical Industries Ltd said it postponed a meeting of shareholders to consider the company's proposed merger with ...
- Sun rejects US firm's proposal to buy Taro stakeSun Pharmaceuticals has rejected a proposal from US investor firm Guggenheim to acquire the Indian firm's stake in Israeli drug firm Taro P...
- Sun rejects Guggenheim’s $215 mn offer for Taro stakeGuggenheim Partners offered to buy Sun Pharmaceutical Industries’ stake in Taro Pharmaceuticals Industries on behalf of clients for about $...
- Glenmark inks licence, supply pact with TaroGlenmark Pharmaceuticals on Thursday said it has signed a licence and supply agreement with Israeli firm Taro Pharmaceuticals to sell a bra...
- Glenmark enters into licence, supply pact with Taro PharmaPharma firm Glenmark Pharmaceuticals on Thursday said that it has entered into a licencing agreement with US-based Taro Pharmaceuticals Inc...
- Co moves court over Taro resultsSun Pharmaceuticals has filed a case against Taro Pharmaceuticals in the Tel Aviv District Court requesting the court to order Taro and its...
- Taro acquisition may cost Sun Pharma Rs 1,000 croreIndian drug firm Sun Pharma may have to shell out up to Rs 1,000 crore this fiscal for acquiring Israel-based Taro Pharmaceuticals.
- Sun, Taro fail to break price deadlockTalks between Mumbai-based Sun Pharmaceuticals and Israel’s Taro Pharmaceuticals have fallen through. In a disclosure to the BSE on Tuesday...
- Sun Pharma to extend Taro offerSun Pharmaceutical will extend its tender offer for all outstanding shares of Taro Pharmaceuticals. which expires on October 3.
- Taro confident of winning case against SunSounding confident of winning the court case against Sun Pharmaceuticals, Israel-based drug firm Taro Pharmaceutical on Monday asked its sh...
Load More
